Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 2752716, 12 pages
https://doi.org/10.1155/2017/2752716
Research Article

Anticancer Effect of Nemopilema nomurai Jellyfish Venom on HepG2 Cells and a Tumor Xenograft Animal Model

1Institute of Animal Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea
2College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea
3Department of Anatomy, College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea
4Headquarters for Marine Environment, National Fisheries Research & Development Institute, Shiran-ri, Gijang-eup, Gijang-gun, Busan 619-705, Republic of Korea

Correspondence should be addressed to Euikyung Kim

Received 2 February 2017; Accepted 5 June 2017; Published 13 July 2017

Academic Editor: Youn C. Kim

Copyright © 2017 Hyunkyoung Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  3. D. Sloane, H. Chen, and C. Howell, “Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival,” Journal of the National Medical Association, vol. 98, no. 12, 1934. View at Google Scholar
  4. A. Gomes, S. Bhattacharya, M. Chakraborty, P. Bhattacharjee, and R. Mishra, “Anti-arthritic activity of Indian monocellate cobra (Naja kaouthia) venom on adjuvant induced arthritis,” Toxicon, vol. 55, no. 2-3, pp. 670–673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-H. Chang and M. L. Bliven, “Anti-arthritic effect of bee venom,” Agents and Actions, vol. 9, no. 2, pp. 205–211, 1979. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. J. Billingham, J. Morley, J. M. Hanson, R. A. Shipolini, and C. A. Vernon, “An Anti-Inflammatory peptide from bee venom,” Nature, vol. 245, no. 5421, pp. 163-164, 1973. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Deshane, C. C. Garner, and H. Sontheimer, “Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2,” Journal of Biological Chemistry, vol. 278, no. 6, pp. 4135–4144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. F. King, “Venoms as a platform for human drugs: translating toxins into therapeutics,” Expert Opinion on Biological Therapy, vol. 11, no. 11, pp. 1469–1484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Mir, S. Karim, M. A. Kamal, C. M. Wilson, and Z. Mirza, “Conotoxins: structure, therapeutic potential and pharmacological applications,” Current Pharmaceutical Design, vol. 22, no. 5, pp. 582–589, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Xu, D. A. Stoffers, J. F. Habener, and S. Bonner-Weir, “Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats,” Diabetes, vol. 48, no. 12, pp. 2270–2276, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Ayed, A. Dellai, H. B. Mansour, H. Bacha, and S. Abid, “Analgesic and antibutyrylcholinestrasic activities of the venom prepared from the Mediterranean jellyfish Pelagia noctiluca (Forsskal, 1775),” Annals of Clinical Microbiology and Antimicrobials, vol. 11, article 15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Azuma, S. Sekizaki, A. Satoh, and T. Nakajima, “Platelet aggregation caused by carybdea rastonii toxins (CrTX-I, II, and III) obtained from a jellyfish, carybdea rastonii,” Proceedings of the Society for Experimental Biology and Medicine, vol. 182, no. 1, pp. 34–42, 1986. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Badré, “Bioactive toxins from stinging jellyfish,” Toxicon, vol. 91, pp. 114–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. L. Brinkman and J. N. Burnell, “Biochemical and molecular characterisation of cubozoan protein toxins,” Toxicon, vol. 54, no. 8, pp. 1162–1173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Kang, A. Munawir, M. Cha et al., “Cytotoxicity and hemolytic activity of jellyfish Nemopilema nomurai (Scyphozoa: Rhizostomeae) venom,” Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, vol. 150, no. 1, pp. 85–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Lee, E.-S. Jung, C. Kang, W. D. Yoon, J.-S. Kim, and E. Kim, “Scyphozoan jellyfish venom metalloproteinases and their role in the cytotoxicity,” Toxicon, vol. 58, no. 3, pp. 277–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Weston, R. Chung, W. C. Dunlap et al., “Proteomic characterisation of toxins isolated from nematocysts of the South Atlantic jellyfish Olindias sambaquiensis,” Toxicon, vol. 71, pp. 11–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Dong, D. Liu, and J. K. Keesing, “Jellyfish blooms in China: dominant species, causes and consequences,” Marine Pollution Bulletin, vol. 60, no. 7, pp. 954–963, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Fu, K. Koo, A. X. Sang, and D. C. Shisler, “Jellyfish envenomation in an ocean swimmer,” Internal and Emergency Medicine, vol. 9, no. 1, pp. 103-104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Frazão and A. Antunes, “Jellyfish bioactive compounds: methods for wet-lab work,” Marine Drugs, vol. 14, no. 4, article no. 75, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Liu, M. Zhang, C. Zhang, and C. Liu, “Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum,” Food Chemistry, vol. 134, no. 4, pp. 2134–2140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Krishnan and P. Pachippan, “Imunomodulatory effects of the jelly fish venom C. quinquecirrha from vellar estuary, southeast coast of India,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 4, pp. 60–62, 2013. View at Google Scholar · View at Scopus
  23. H. Yu, X. Liu, X. Dong et al., “Insecticidal activity of proteinous venom from tentacle of jellyfish Rhopilema esculentum Kishinouye,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 22, pp. 4949–4952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Rastogi, S. Biswas, A. Sarkar, and D. Chakrabarty, “Anticoagulant activity of Moon jellyfish (Aurelia aurita) tentacle extract,” Toxicon, vol. 60, no. 5, pp. 719–723, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. Bloom, J. W. Burnett, and P. Alderslade, “Partial purification of box jellyfish (Chironex fleckeri) nematocyst venom isolated at the beachside,” Toxicon, vol. 36, no. 8, pp. 1075–1085, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Seymour, T. Carrette, P. Cullen, M. Little, R. F. Mulcahy, and P. L. Pereira, “The use of pressure immobilization bandages in the first aid management of cubozoan envenomings,” Toxicon, vol. 40, no. 10, pp. 1503–1505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Kim, M. Emi, and K. Tanabe, “Caspase-dependent and -independent cell death pathways after DNA damage (Review),” Oncology Reports, 2005. View at Publisher · View at Google Scholar
  29. A. H. Boulares, A. G. Yakovlev, V. Ivanova et al., “Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells,” The Journal of Biological Chemistry, vol. 274, no. 33, pp. 22932–22940, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. L. C. Cantley and B. G. Neel, “New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 8, pp. 4240–4245, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. T. F. Franke, C. P. Hornik, L. Segev, G. A. Shostak, and C. Sugimoto, “PI3K/Akt and apoptosis: size matters,” Oncogene, vol. 22, no. 56, pp. 8983–8998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. H. A. Burris III, “Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway,” Cancer Chemotherapy and Pharmacology, vol. 71, no. 4, pp. 829–842, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. A. Wander, B. T. Hennessy, and J. M. Slingerland, “Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy,” Journal of Clinical Investigation, vol. 121, no. 4, pp. 1231–1241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Morishige, T. Sugahara, S. Nishimoto et al., “Immunostimulatory effects of collagen from jellyfish in vivo,” Cytotechnology, vol. 63, no. 5, pp. 481–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Ohta, M. Sato, K. Ushida et al., “Jellyfish mucin may have potential disease-modifying effects on osteoarthritis,” BMC Biotechnology, vol. 9, article no. 98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. H. Park, M. S. Choi, D. H. Kwak et al., “Anti-cancer effect of bee venomin prostate cancer cells through activation of caspase pathway via inactivation of NF-κB,” Prostate, vol. 71, no. 8, pp. 801–812, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. E. Choi, C. J. Hwang, S. M. Gu et al., “Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells,” Toxins, vol. 6, no. 8, pp. 2210–2228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Liu, X.-Y. Xiao, Q.-Y. Shou et al., “Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway,” Journal of Ethnopharmacology, vol. 193, pp. 538–545, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Thakur, S. Kini, S. Kurkalang et al., “Mechanism of apoptosis induction in human breast cancer MCF-7 cell by Ruviprase, a small peptide from Daboia russelii russelii venom,” Chemico-Biological Interactions, vol. 258, pp. 297–304, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-S. Chen, Q. Wang, X.-H. Fu et al., “Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9,” Hepatology Research, vol. 39, no. 2, pp. 177–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Samuels, Z. Wang, A. Bardelli et al., “High frequency of mutations of the PIK3CA gene in human cancers,” Science, vol. 304, no. 5670, p. 554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Villanueva, D. Y. Chiang, P. Newell et al., “Pivotal role of mTOR signaling in hepatocellular carcinoma,” Gastroenterology, vol. 135, no. 6, pp. 1972.e11–1983.e11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Chaisakul, W. C. Hodgson, S. Kuruppu, and N. Prasongsook, “Effects of animal venoms and toxins on hallmarks of cancer,” Journal of Cancer, vol. 7, no. 11, pp. 1571–1578, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Tanjoni, R. Weinlich, M. S. Della-Casa et al., “Jararhagin, a snake venom metalloproteinase, induces a specialized form of apoptosis (anoikis) selective to endothelial cells,” Apoptosis, vol. 10, no. 4, pp. 851–861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. C. Corrêa Jr., D. A. Maria, A. M. Moura-Da-Silva, K. F. Pizzocaro, and I. R. G. Ruiz, “Inhibition of melanoma cells tumorigenicity by the snake venom toxin jararhagin,” Toxicon, vol. 40, no. 6, pp. 739–748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. D. A. Maria, M. G. L. da Silva, M. C. Correia, and I. R. G. Ruiz, “Antiproliferative effect of the jararhagin toxin on B16F10 murine melanoma,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 446, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. S.-G. Wan, Y. Jin, W.-H. Lee, and Y. Zhang, “A snake venom metalloproteinase that inhibited cell proliferation and induced morphological changes of ECV304 cells,” Toxicon, vol. 47, no. 4, pp. 480–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Yanagihara and R. V. Shohet, “Cubozoan venom-induced cardiovascular collapse is caused by hyperkalemia and prevented by zinc gluconate in mice,” PLoS ONE, vol. 7, no. 12, Article ID e51368, 2012. View at Publisher · View at Google Scholar · View at Scopus